Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Abbott Laboratories (ABT) Stock-Based Compensation data is not available for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$11.16B |
|
$1.08B |
|
$4.89B |
|
$6.27B |
|
$9.82B |
|
$1.34B |
|
$104.00M |
|
$1.45B |
|
$1.45B |
|
$1.08B |
|
$1.08B |
|
$1.08B |
|
$1.08B |
|
$1.34B |
|
-- |
|
-- |
|
1.75B |
|
-- |
|
$0.61 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Stock-Based Compensation |
-- |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|